{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:02:06Z","timestamp":1788472926774,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T00:00:00Z","timestamp":1635552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s11033-021-06886-w","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T09:02:39Z","timestamp":1635584559000},"page":"403-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Blocking neddylation elicits antiviral effect against hepatitis B virus replication"],"prefix":"10.1007","volume":"49","author":[{"given":"Karima","family":"Abounouh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Enamul Hoque","family":"Kayesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya","family":"Altawalah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouchra","family":"Kitab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuko","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hind","family":"Dehbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michinori","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumaya","family":"Benjelloun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Tsukiyama-Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-6163","authenticated-orcid":false,"given":"Sayeh","family":"Ezzikouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,30]]},"reference":[{"key":"6886_CR1","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","volume":"373","author":"YF Liaw","year":"2009","unstructured":"Liaw YF, Chu CM (2009) Hepatitis B virus infection. Lancet 373:582\u2013592","journal-title":"Lancet"},{"key":"6886_CR2","unstructured":"WHO (2021) Hepatitis B. Key facts. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b. Accessed 15 September 2021"},{"key":"6886_CR3","doi-asserted-by":"publisher","first-page":"103990","DOI":"10.1016\/j.meegid.2019.103990","volume":"75","author":"K Abounouh","year":"2019","unstructured":"Abounouh K, Aitraise I, Benabou A, Boussakri I, Doumir MA, El Boussairi C, El Idrissi S, El Mahdaoui C, Qouar DE, Ennahal A, Fathi S, Hafidi M, Lachker L, Ratib C, Tanouti IA, Maaroufi A, Benjelloun S, Guessous F, Pineau P, Ezzikouri S (2019) Virus-associated human cancers in Moroccan population: from epidemiology to prospective research. Infect Genet Evol 75:103990","journal-title":"Infect Genet Evol"},{"key":"6886_CR4","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Trepo","year":"2014","unstructured":"Trepo C, Chan HL, Lok A (2014) Hepatitis B virus infection. Lancet 384:2053\u20132063","journal-title":"Lancet"},{"key":"6886_CR5","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/jmv.23916","volume":"86","author":"S Ezzikouri","year":"2014","unstructured":"Ezzikouri S, Ozawa M, Kohara M, Elmdaghri N, Benjelloun S, Tsukiyama-Kohara K (2014) Recent insights into hepatitis B virus-host interactions. J Med Virol 86:925\u2013932","journal-title":"J Med Virol"},{"key":"6886_CR6","doi-asserted-by":"publisher","first-page":"586881","DOI":"10.3389\/fmed.2020.586881","volume":"7","author":"J Yao","year":"2020","unstructured":"Yao J, Liang X, Liu Y, Zheng M (2020) Neddylation: a versatile pathway takes on chronic liver diseases. Front Med (Lausanne) 7:586881","journal-title":"Front Med (Lausanne)"},{"key":"6886_CR7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.cell.2008.07.022","volume":"134","author":"DM Duda","year":"2008","unstructured":"Duda DM, Borg LA, Scott DC, Hunt HW, Hammel M, Schulman BA (2008) Structural insights into NEDD8 activation of cullin-RING ligases: conformational control of conjugation. Cell 134:995\u20131006","journal-title":"Cell"},{"key":"6886_CR8","doi-asserted-by":"crossref","unstructured":"Liu N, Zhang J, Yang X, Jiao T, Zhao X, Li W, Zhu J, Yang P, Jin J, Peng J, Li Z, Ye X (2017) HDM2 promotes NEDDylation of hepatitis B virus HBx to enhance its stability and function. J Virol 91:e00340-17","DOI":"10.1128\/JVI.00340-17"},{"key":"6886_CR9","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/sj.onc.1207414","volume":"23","author":"ZQ Pan","year":"2004","unstructured":"Pan ZQ, Kentsis A, Dias DC, Yamoah K, Wu K (2004) Nedd8 on cullin: building an expressway to protein destruction. Oncogene 23:1985\u20131997","journal-title":"Oncogene"},{"key":"6886_CR10","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.bbrc.2014.07.019","volume":"450","author":"L Guo","year":"2014","unstructured":"Guo L, Wang X, Ren L, Zeng M, Wang S, Weng Y, Tang Z, Wang X, Tang Y, Hu H, Li M, Zhang C, Liu C (2014) HBx affects CUL4-DDB1 function in both positive and negative manners. Biochem Biophys Res Commun 450:1492\u20131497","journal-title":"Biochem Biophys Res Commun"},{"key":"6886_CR11","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nsmb.1719","volume":"17","author":"T Li","year":"2010","unstructured":"Li T, Robert EI, van Breugel PC, Strubin M, Zheng N (2010) A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery. Nat Struct Mol Biol 17:105\u2013111","journal-title":"Nat Struct Mol Biol"},{"key":"6886_CR12","first-page":"e00340","volume":"91","author":"N Liu","year":"2017","unstructured":"Liu N, Zhang J, Yang X, Jiao T, Zhao X, Li W, Zhu J, Yang P, Jin J, Peng J, Li Z, Ye X (2017) HDM2 promotes NEDDylation of hepatitis B virus HBx to enhance its stability and function. J Virol 91:e00340\u2013e00317","journal-title":"J Virol"},{"key":"6886_CR13","doi-asserted-by":"crossref","unstructured":"Elmessaoudi-Idrissi M, Windisch MP, Kettani A, Altawalah H, Pineau P, Benjelloun S, Ezzikouri S (2020) An integrative gene expression microarray meta-analysis identifies host factors and key signatures involved in hepatitis B Virus infection. Infect Disord Drug Targets 20:698\u2013707","DOI":"10.2174\/1871526519666190807153901"},{"key":"6886_CR14","doi-asserted-by":"publisher","first-page":"198191","DOI":"10.1016\/j.virusres.2020.198191","volume":"290","author":"MEH Kayesh","year":"2020","unstructured":"Kayesh MEH, Amako Y, Hashem MA, Murakami S, Ogawa S, Yamamoto N, Hifumi T, Miyoshi N, Sugiyama M, Tanaka Y, Mizokami M, Kohara M, Tsukiyama-Kohara K (2020) Development of an in vivo delivery system for CRISPR\/Cas9-mediated targeting of hepatitis B virus cccDNA. Virus Res 290:198191","journal-title":"Virus Res"},{"key":"6886_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bbrc.2014.08.029","volume":"452","author":"N Ogura","year":"2014","unstructured":"Ogura N, Watashi K, Noguchi T, Wakita T (2014) Formation of covalently closed circular DNA in Hep38.7-Tet cells, a tetracycline inducible hepatitis B virus expression cell line. Biochem Biophys Res Commun 452:315\u2013321","journal-title":"Biochem Biophys Res Commun"},{"key":"6886_CR16","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1073\/pnas.84.4.1005","volume":"84","author":"MA Sells","year":"1987","unstructured":"Sells MA, Chen ML, Acs G (1987) Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84:1005\u20131009","journal-title":"Proc Natl Acad Sci USA"},{"key":"6886_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/JCM.40.2.439-445.2002","volume":"40","author":"T Kimura","year":"2002","unstructured":"Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, Maki N (2002) Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. J Clin Microbiol 40:439\u2013445","journal-title":"J Clin Microbiol"},{"issue":"Suppl 1","key":"6886_CR18","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/S0168-8278(12)60012-9","volume":"56","author":"F Zoulim","year":"2012","unstructured":"Zoulim F, Locarnini S (2012) Management of treatment failure in chronic hepatitis B. J Hepatol 56(Suppl 1):S112\u2013S122","journal-title":"J Hepatol"},{"key":"6886_CR19","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","volume":"137","author":"F Zoulim","year":"2009","unstructured":"Zoulim F, Locarnini S (2009) Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 137:1593-1608e1591","journal-title":"Gastroenterology"},{"key":"6886_CR20","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/jcmm.16137","volume":"25","author":"M Xie","year":"2021","unstructured":"Xie M, Guo H, Lou G, Yao J, Liu Y, Sun Y, Yang Z, Zheng M (2021) Neddylation inhibitor MLN4924 has anti-HBV activity via modulating the ERK-HNF1\u03b1-C\/EBP\u03b1-HNF4\u03b1 axis. J Cell Mol Med 25:840\u2013854","journal-title":"J Cell Mol Med"},{"key":"6886_CR21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coviro.2018.01.007","volume":"30","author":"BL Slagle","year":"2018","unstructured":"Slagle BL, Bouchard MJ (2018) Role of HBx in hepatitis B virus persistence and its therapeutic implications. Curr Opin Virol 30:32\u201338","journal-title":"Curr Opin Virol"},{"key":"6886_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature17170","volume":"531","author":"A Decorsi\u00e8re","year":"2016","unstructured":"Decorsi\u00e8re A, Mueller H, van Breugel PC, Abdul F, Gerossier L, Beran RK, Livingston CM, Niu C, Fletcher SP, Hantz O, Strubin M (2016) Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor. Nature 531:386\u2013389","journal-title":"Nature"},{"key":"6886_CR23","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","volume":"16","author":"CM Murphy","year":"2016","unstructured":"Murphy CM, Xu Y, Li F, Nio K, Reszka-Blanco N, Li X, Wu Y, Yu Y, Xiong Y, Su L (2016) Hepatitis B virus X protein promotes degradation of SMC5\/6 to enhance HBV replication. Cell Rep 16:2846\u20132854","journal-title":"Cell Rep"},{"key":"6886_CR24","first-page":"e00722","volume":"92","author":"Y Xia","year":"2018","unstructured":"Xia Y, Cheng X, Li Y, Valdez K, Chen W, Liang TJ (2018) Hepatitis B virus deregulates the cell cycle to promote viral replication and a premalignant phenotype. J Virol 92:e00722\u2013e00718","journal-title":"J Virol"},{"key":"6886_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1423-0127-18-96","volume":"18:","author":"CL Chong","year":"2011","unstructured":"Chong CL, Chen ML, Wu YC, Tsai KN, Huang CC, Hu CP, Jeng KS, Chou YC, Chang C (2011) Dynamics of HBV cccDNA expression and transcription in different cell growth phase. J Biomed Sci 18::96","journal-title":"J Biomed Sci"},{"key":"6886_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0923-2516(98)80085-X","volume":"149","author":"WX Wang","year":"1998","unstructured":"Wang WX, Li M, Wu X, Wang Y, Li ZP (1998) HNF1 is critical for the liver-specific function of HBV enhancer II. Res Virol 149:99\u2013108","journal-title":"Res Virol"},{"key":"6886_CR27","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1128\/jvi.65.11.5774-5781.1991","volume":"65","author":"AK Raney","year":"1991","unstructured":"Raney AK, Easton AJ, Milich DR, McLachlan A (1991) Promoter-specific transactivation of hepatitis B virus transcription by a glutamine- and proline-rich domain of hepatocyte nuclear factor 1. J Virol 65:5774\u20135781","journal-title":"J Virol"},{"key":"6886_CR28","first-page":"1353","volume":"11","author":"DX Zhou","year":"1991","unstructured":"Zhou DX, Yen TS (1991) The ubiquitous transcription factor Oct-1 and the liver-specific factor HNF-1 are both required to activate transcription of a hepatitis B virus promoter. Mol Cell Biol 11:1353\u20131359","journal-title":"Mol Cell Biol"},{"key":"6886_CR29","doi-asserted-by":"publisher","first-page":"30181","DOI":"10.1074\/jbc.M112.370312","volume":"287","author":"Z Zhao","year":"2012","unstructured":"Zhao Z, Hong W, Zeng Z, Wu Y, Hu K, Tian X, Li W, Cao Z (2012) Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4\u03b1 in vitro and in vivo. J Biol Chem 287:30181\u201330190","journal-title":"J Biol Chem"},{"key":"6886_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41401-019-0302-0","volume":"41","author":"ZY Wang","year":"2020","unstructured":"Wang ZY, Li YQ, Guo ZW, Zhou XH, Lu MD, Xue TC, Gao B (2020) ERK1\/2-HNF4\u03b1 axis is involved in epigallocatechin-3-gallate inhibition of HBV replication. Acta Pharmacol Sin 41:278\u2013285","journal-title":"Acta Pharmacol Sin"},{"key":"6886_CR31","doi-asserted-by":"publisher","first-page":"104568","DOI":"10.1016\/j.antiviral.2019.104568","volume":"170","author":"L Li","year":"2019","unstructured":"Li L, Li Y, Xiong Z, Shu W, Yang Y, Guo Z, Gao B (2019) FoxO4 inhibits HBV core promoter activity through ERK-mediated downregulation of HNF4\u03b1. Antiviral Res 170:104568","journal-title":"Antiviral Res"},{"key":"6886_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2893.2010.01315.x","volume":"17","author":"M Quasdorff","year":"2010","unstructured":"Quasdorff M, Protzer U (2010) Control of hepatitis B virus at the level of transcription. J Viral Hepat 17:527\u2013536","journal-title":"J Viral Hepat"},{"key":"6886_CR33","first-page":"S-1194","volume":"156","author":"K Sekiba","year":"2019","unstructured":"Sekiba K, Otsuka M, Ko K (2019) Pevonedistat, a first-in-class nedd8-activating enzyme inhibitor, is a potent inhibitor of hepatitis B virus. AASLD Abstr 402 Gastroenterol 156:S-1194","journal-title":"AASLD Abstr 402 Gastroenterol"},{"key":"6886_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020216","author":"S Ezzikouri","year":"2020","unstructured":"Ezzikouri S, Kayesh MEH, Benjelloun S, Kohara M, Tsukiyama-Kohara K (2020) Targeting host innate and adaptive immunity to achieve the functional cure of chronic hepatitis B. Vaccines (Basel) 8:216","journal-title":"Vaccines (Basel)"},{"key":"6886_CR35","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","volume":"64","author":"M Nassal","year":"2015","unstructured":"Nassal M (2015) HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B. Gut 64:1972\u20131984","journal-title":"Gut"},{"key":"6886_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0092-8674(86)90602-1","volume":"47","author":"JS Tuttleman","year":"1986","unstructured":"Tuttleman JS, Pourcel C, Summers J (1986) Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 47:451\u2013460","journal-title":"Cell"},{"key":"6886_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/0042-6822(90)90206-7","volume":"175","author":"TT Wu","year":"1990","unstructured":"Wu TT, Coates L, Aldrich CE, Summers J, Mason WS (1990) In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 175:255\u2013261","journal-title":"Virology"},{"key":"6886_CR38","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jhep.2016.02.009","volume":"64:","author":"J Lucifora","year":"2016","unstructured":"Lucifora J, Protzer U (2016) Attacking hepatitis B virus cccDNA\u2014the holy grail to hepatitis B cure. J Hepatol 64:S41\u2013S48","journal-title":"J Hepatol"},{"key":"6886_CR39","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.jhep.2018.08.012","volume":"69","author":"C Ko","year":"2018","unstructured":"Ko C, Chakraborty A, Chou WM, Hasreiter J, Wettengel JM, Stadler D, Bester R, Asen T, Zhang K, Wisskirchen K, McKeating JA, Ryu WS, Protzer U (2018) Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels. J Hepatol 69:1231\u20131241","journal-title":"J Hepatol"},{"key":"6886_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1128\/JVI.75.1.311-322.2001","volume":"75","author":"Y Zhu","year":"2001","unstructured":"Zhu Y, Yamamoto T, Cullen J, Saputelli J, Aldrich CE, Miller DS, Litwin S, Furman PA, Jilbert AR, Mason WS (2001) Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis. J Virol 75:311\u2013322","journal-title":"J Virol"},{"key":"6886_CR41","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1128\/JVI.76.12.6356-6363.2002","volume":"76","author":"WR Addison","year":"2002","unstructured":"Addison WR, Walters KA, Wong WW, Wilson JS, Madej D, Jewell LD, Tyrrell DL (2002) Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. J Virol 76:6356\u20136363","journal-title":"J Virol"},{"key":"6886_CR42","doi-asserted-by":"publisher","first-page":"17780","DOI":"10.1073\/pnas.0508913102","volume":"102","author":"JM Murray","year":"2005","unstructured":"Murray JM, Wieland SF, Purcell RH, Chisari FV (2005) Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci USA 102:17780\u201317785","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06886-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06886-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T14:31:09Z","timestamp":1641825069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06886-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,30]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["6886"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06886-w","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,30]]},"assertion":[{"value":"27 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article did not contain any study with human participants or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animal participants"}}]}}